We found that as many as eight ASOs effectively redirected BIM splicing from E3 to E4, and reconstitute the TKI-mediated responses in two different CML cell lines. This evidence concerns the gene BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive.